Shell Asset Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$14K Sell
3,392
-3,984
-54% -$17.5K ﹤0.01% 1083
2025
Q2
$37K Sell
7,376
-786
-10% -$3.41K ﹤0.01% 1184
2025
Q1
$36K Sell
8,162
-343
-4% -$1.61K ﹤0.01% 1193
2024
Q4
$40K Hold
8,505
﹤0.01% 1200
2024
Q3
$59K Buy
+8,505
New +$66.8K ﹤0.01% 1158
2024
Q1
$70K Sell
8,977
-631
-7% -$4.17K ﹤0.01% 1099
2023
Q4
$64K Sell
9,608
-2,827
-23% -$15.9K ﹤0.01% 1136
2023
Q3
$70K Sell
12,435
-193
-2% -$1.29K ﹤0.01% 1148
2023
Q2
$70K Sell
12,628
-72
-0.6% -$387 ﹤0.01% 1177
2023
Q1
$79K Sell
12,700
-44
-0.3% -$245 ﹤0.01% 1150
2022
Q4
$59K Sell
12,744
-927
-7% -$4.57K ﹤0.01% 1243
2022
Q3
$64K Sell
13,671
-1,815
-12% -$11.4K ﹤0.01% 1303
2022
Q2
$92K Buy
+15,486
New +$172K ﹤0.01% 1300

Other funds holding GDRX

Shell Asset Management's GDRX Position: Q3 2025 in Review

Shell Asset Management reduced its GoodRx Holdings (GDRX) stake by 54% in Q3 2025, selling an estimated $17.5K and leaving 3,392 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #1083.

Shell Asset Management first reported a position in GDRX in Q2 2022 and has held it in 13 quarters since. The position peaked at $92K in Q2 2022. 161 funds tracked by Wall St. Rank hold GDRX as of Q3 2025.

  • Shell Asset Management held 3,392 shares of GoodRx Holdings worth $14K as of Q3 2025.
  • Shell Asset Management sold 3,984 GoodRx Holdings shares in Q3 2025, an estimated $17.5K.
  • GoodRx Holdings made up ﹤0.01% of Shell Asset Management's portfolio in Q3 2025, its #1083 holding.
  • Shell Asset Management first reported a position in GoodRx Holdings in Q2 2022 and has held it in 13 quarters since.
  • Shell Asset Management's GoodRx Holdings position peaked at $92K in Q2 2022.
  • 161 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.